Your browser doesn't support javascript.
loading
Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
Jarzabek, Monika A; Proctor, William R; Vogt, Jennifer; Desai, Rupal; Dicker, Patrick; Cain, Gary; Raja, Rajiv; Brodbeck, Jens; Stevens, Dale; van der Stok, Eric P; Martens, John W M; Verhoef, Cornelis; Hegde, Priti S; Byrne, Annette T; Tarrant, Jacqueline M.
Afiliação
  • Jarzabek MA; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Proctor WR; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • Vogt J; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • Desai R; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.
  • Dicker P; Department of Epidemiology and Public Health Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Cain G; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • Raja R; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.
  • Brodbeck J; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • Stevens D; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • van der Stok EP; Department of Surgical Oncology, Erasmus MC, Rotterdam, Netherlands.
  • Martens JWM; Department of Medical Oncology, Erasmus MC, Rotterdam, Netherlands.
  • Verhoef C; Department of Surgical Oncology, Erasmus MC, Rotterdam, Netherlands.
  • Hegde PS; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.
  • Byrne AT; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Tarrant JM; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
PLoS One ; 13(6): e0198099, 2018.
Article em En | MEDLINE | ID: mdl-29879147
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Doença Hepática Induzida por Substâncias e Drogas / Transcriptoma / Oxaliplatina / Fígado Tipo de estudo: Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Irlanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Doença Hepática Induzida por Substâncias e Drogas / Transcriptoma / Oxaliplatina / Fígado Tipo de estudo: Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Irlanda